AstraZeneca-Oxford COVID-19 vaccine Trial Paused after participant falls ill. AstraZeneca described it as a “routine” pause in the case of “an unexplained illness”. The outcome of vaccine trials is being closely watched around the world. The AstraZeneca-Oxford University vaccine is seen as a strong contender among dozens being developed globally.
The AstraZeneca issued a statement on September 8, 2020 saying that late-stage studies of its vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot.
Vaccine might be one of the first to come on the market, following successful phase 1 and 2 testing. Its move to Phase 3 testing in recent weeks has involved some 30,000 participants in the US as well as in the UK, Brazil and South Africa. Phase 3 trials in vaccines often involve thousands of participants and can last several years.
Vaccine Trials in India?
AstraZeneca has tied up with private vaccine manufacturer Serum Institute of India (SII) to manufacture doses of the vaccine once it gets the required approval. The Serum Institute is also conducting clinical trials of the vaccine in India. The institute had earlier sought regulatory licensing from the authorities for the same.
Speaking on the pause in UK trials of the vaccine, Serum Institute of India stated that it cannot comment on it but they have been paused for further review and hope restart soon. As far as Indian trials are concerned, the Serum Institute confirmed that it is continuing and they have faced no issues at all.
Other Vaccines in final stage of trials:
Two other COVID-19 vaccine candidates are in final-stage trials in the United States- one developed by Moderna Inc. and the other developed by Pfizer and Germany’s BioNTech. These two vaccines work differently from the AstraZeneca-Oxford COVID vaccine and their studies have already recruited about two-thirds of the needed volunteers.
|For Online Test Series||Click Here|
|To Join Whatsapp
|To Subscribe Youtube||Click Here|
|To Join Telegram Channel
|To Join Facebook||Click Here|